fda warning bpc 157 unapproved drug marketing warning letter On August 15 2025, the U.S. Food & Administration (FDA) issued a to Platinum Biologics LLC for umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Treat Gastrointestinal pathology bpc 157 capsule or Fragrance:Original

fda warning bpc 157 unapproved drug marketing warning letter On August 15 2025, the U.S. Food & Administration (FDA) issued a to Platinum Biologics LLC for umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Treat Gastrointestinal pathology bpc 157 capsule or Fragrance:Original

bpc 157 capsule or injection Oral BPC-157 bpc-157 oral bioavailability studies vs –

Batch-specific third-party testing, published per lot

Treat Gastrointestinal pathology

Fragrance:Original

The COVID-19 pandemic has had a worldwide impact and multiple studies have shown the immunological effects of this disease